Segal, Benjamin

Feb 27, 2019 | Investigator Profiles

Benjamin Segal

Associated Articles

RespireRx Pharmaceuticals Inc. Announces $2 Million Funding Commitment Allowing Option Exercise with UWM Research Foundation, Inc. and Entry into a License Agreement for GABA(A) Receptor Allosteric Neuromodulator Intellectual Property

Glen Rock, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), has historically been and remains a leader in the research and development of ampakines for a variety of central nervous system (CNS)...

The Urgent Need for Pediatric COVID-19 Clinical Trials

The Urgent Need for Pediatric COVID-19 Clinical Trials

Authors Jeffrey I. Campbell, Karen E. Ocwieja, and Mari M. Nakamura are calling for pediatric COVID-19 clinical trials. According to them, “We need pediatric clinical trials to establish the efficacy, safety, and pharmacokinetics of the most promising experimental and...


Pin It on Pinterest